サマリー

腎臓結石の世界市場 2023-2027
Technavioは、腎臓結石市場をモニターしており、2022年から2027年の間に5億6678万米ドルで成長し、予測期間中のCAGRは5.42%で加速すると予測しています。当レポートでは、腎臓結石市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、フレキシブルデジタル尿管鏡の普及、世界人口における尿路結石の発生率の上昇、腎臓結石症の有病率の上昇によって牽引されています。
Technavioの腎臓結石市場は以下のようにセグメント化されています：
タイプ別
- 尿管内視鏡検査
- リソトリプシー
- 経皮的腎結石摘出術(PCNL)
エンドユーザー別
- ホスピタルズ
- スペシャリティクリニック
- 外来手術センター（Ambulatory surgical centers
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、腎臓結石治療における技術の進歩が、今後数年間の腎臓結石市場の成長を促進する主要な理由の1つであると特定しています。また、老年人口の増加や、国民の意識向上、医師の教育、臨床トレーニングの取り組みが、市場の大きな需要につながると考えられます。
Technavioは、複数の情報源からのデータを、主要パラメータの分析によって調査、合成、総括する方法で、市場の詳細な姿を提示します。当レポートでは、腎臓結石市場について、以下の分野を取り上げています：
- 腎臓結石市場のサイジング
- 腎臓結石の市場予測
- 腎臓結石市場の産業分析
Technavioの強固なベンダー分析は、お客様が市場での地位を向上させることを目的としており、これに沿って本レポートでは、Anvik Biotech, Aristo Pharma GmbH, Bausch Health Co Inc., Biomedix Siomond Pharma, Cipla Ltd., Cmg Biotech Pvt. Ltd.など複数の腎臓結石市場主要ベンダーについて詳細に分析を行っています、Dr Reddys Laboratories Ltd.、Emcure Pharmaceuticals Ltd.、GlaxoSmithKline Plc、Intas Pharmaceuticals Ltd.、Johnson and Johnson、Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Walter Bushnell, Windlas Biotech Pvt. Ltd, Worth Medicines Pvt. Ltd, Pfizer Inc, and Bayer AG.また、腎臓結石市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/kidney-stones-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global kidney stones market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global kidney stones market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Ureteroscopy - Market size and forecast 2022-2027
o Exhibit 34: Chart on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Ureteroscopy - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Ureteroscopy - Year-over-year growth 2022-2027 (%)
o 6.4 Lithotripsy - Market size and forecast 2022-2027
o Exhibit 38: Chart on Lithotripsy - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Lithotripsy - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Lithotripsy - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Lithotripsy - Year-over-year growth 2022-2027 (%)
o 6.5 Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027
o Exhibit 42: Chart on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ million)
o Exhibit 47: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 50: Chart on Comparison by End-user
o Exhibit 51: Data Table on Comparison by End-user
o 7.3 Hospitals - Market size and forecast 2022-2027
o Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 7.4 Specialty clinics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)
o 7.5 Ambulatory surgical centers - Market size and forecast 2022-2027
o Exhibit 60: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2022-2027 (%)
o Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ million)
o Exhibit 108: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Anvik Biotech
o Exhibit 115: Anvik Biotech - Overview
o Exhibit 116: Anvik Biotech - Product / Service
o Exhibit 117: Anvik Biotech - Key offerings
o 12.4 Aristo Pharma GmbH
o Exhibit 118: Aristo Pharma GmbH - Overview
o Exhibit 119: Aristo Pharma GmbH - Product / Service
o Exhibit 120: Aristo Pharma GmbH - Key offerings
o 12.5 Bausch Health Co Inc.
o Exhibit 121: Bausch Health Co Inc. - Overview
o Exhibit 122: Bausch Health Co Inc. - Business segments
o Exhibit 123: Bausch Health Co Inc. - Key news
o Exhibit 124: Bausch Health Co Inc. - Key offerings
o Exhibit 125: Bausch Health Co Inc. - Segment focus
o 12.6 Bayer AG
o Exhibit 126: Bayer AG - Overview
o Exhibit 127: Bayer AG - Business segments
o Exhibit 128: Bayer AG - Key news
o Exhibit 129: Bayer AG - Key offerings
o Exhibit 130: Bayer AG - Segment focus
o 12.7 Cipla Ltd.
o Exhibit 131: Cipla Ltd. - Overview
o Exhibit 132: Cipla Ltd. - Business segments
o Exhibit 133: Cipla Ltd. - Key news
o Exhibit 134: Cipla Ltd. - Key offerings
o Exhibit 135: Cipla Ltd. - Segment focus
o 12.8 Dr Reddys Laboratories Ltd.
o Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus
o 12.9 Emcure Pharmaceuticals Ltd.
o Exhibit 140: Emcure Pharmaceuticals Ltd. - Overview
o Exhibit 141: Emcure Pharmaceuticals Ltd. - Product / Service
o Exhibit 142: Emcure Pharmaceuticals Ltd. - Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc - Overview
o Exhibit 144: GlaxoSmithKline Plc - Business segments
o Exhibit 145: GlaxoSmithKline Plc - Key offerings
o Exhibit 146: GlaxoSmithKline Plc - Segment focus
o 12.11 Intas Pharmaceuticals Ltd.
o Exhibit 147: Intas Pharmaceuticals Ltd. - Overview
o Exhibit 148: Intas Pharmaceuticals Ltd. - Product / Service
o Exhibit 149: Intas Pharmaceuticals Ltd. - Key offerings
o 12.12 Macleods Pharmaceuticals Ltd.
o Exhibit 150: Macleods Pharmaceuticals Ltd. - Overview
o Exhibit 151: Macleods Pharmaceuticals Ltd. - Product / Service
o Exhibit 152: Macleods Pharmaceuticals Ltd. - Key offerings
o 12.13 Medinova Diagnostic Services Ltd.
o Exhibit 153: Medinova Diagnostic Services Ltd. - Overview
o Exhibit 154: Medinova Diagnostic Services Ltd. - Product / Service
o Exhibit 155: Medinova Diagnostic Services Ltd. - Key offerings
o 12.14 Pfizer Inc.
o Exhibit 156: Pfizer Inc. - Overview
o Exhibit 157: Pfizer Inc. - Product / Service
o Exhibit 158: Pfizer Inc. - Key news
o Exhibit 159: Pfizer Inc. - Key offerings
o 12.15 Walter Bushnell
o Exhibit 160: Walter Bushnell - Overview
o Exhibit 161: Walter Bushnell - Product / Service
o Exhibit 162: Walter Bushnell - Key offerings
o 12.16 Windlas Biotech Pvt. Ltd.
o Exhibit 163: Windlas Biotech Pvt. Ltd. - Overview
o Exhibit 164: Windlas Biotech Pvt. Ltd. - Product / Service
o Exhibit 165: Windlas Biotech Pvt. Ltd. - Key offerings
o 12.17 Worth Medicines Pvt. Ltd.
o Exhibit 166: Worth Medicines Pvt. Ltd. - Overview
o Exhibit 167: Worth Medicines Pvt. Ltd. - Product / Service
o Exhibit 168: Worth Medicines Pvt. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global kidney stones market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Ureteroscopy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Ureteroscopy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Lithotripsy - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Lithotripsy - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Lithotripsy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Lithotripsy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on End-user - Market share 2022-2027 (%)
Exhibits49: Data Table on End-user - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Anvik Biotech - Overview
Exhibits116: Anvik Biotech - Product / Service
Exhibits117: Anvik Biotech - Key offerings
Exhibits118: Aristo Pharma GmbH - Overview
Exhibits119: Aristo Pharma GmbH - Product / Service
Exhibits120: Aristo Pharma GmbH - Key offerings
Exhibits121: Bausch Health Co Inc. - Overview
Exhibits122: Bausch Health Co Inc. - Business segments
Exhibits123: Bausch Health Co Inc. - Key news
Exhibits124: Bausch Health Co Inc. - Key offerings
Exhibits125: Bausch Health Co Inc. - Segment focus
Exhibits126: Bayer AG - Overview
Exhibits127: Bayer AG - Business segments
Exhibits128: Bayer AG - Key news
Exhibits129: Bayer AG - Key offerings
Exhibits130: Bayer AG - Segment focus
Exhibits131: Cipla Ltd. - Overview
Exhibits132: Cipla Ltd. - Business segments
Exhibits133: Cipla Ltd. - Key news
Exhibits134: Cipla Ltd. - Key offerings
Exhibits135: Cipla Ltd. - Segment focus
Exhibits136: Dr Reddys Laboratories Ltd. - Overview
Exhibits137: Dr Reddys Laboratories Ltd. - Business segments
Exhibits138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits139: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits140: Emcure Pharmaceuticals Ltd. - Overview
Exhibits141: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibits142: Emcure Pharmaceuticals Ltd. - Key offerings
Exhibits143: GlaxoSmithKline Plc - Overview
Exhibits144: GlaxoSmithKline Plc - Business segments
Exhibits145: GlaxoSmithKline Plc - Key offerings
Exhibits146: GlaxoSmithKline Plc - Segment focus
Exhibits147: Intas Pharmaceuticals Ltd. - Overview
Exhibits148: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits149: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits150: Macleods Pharmaceuticals Ltd. - Overview
Exhibits151: Macleods Pharmaceuticals Ltd. - Product / Service
Exhibits152: Macleods Pharmaceuticals Ltd. - Key offerings
Exhibits153: Medinova Diagnostic Services Ltd. - Overview
Exhibits154: Medinova Diagnostic Services Ltd. - Product / Service
Exhibits155: Medinova Diagnostic Services Ltd. - Key offerings
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Walter Bushnell - Overview
Exhibits161: Walter Bushnell - Product / Service
Exhibits162: Walter Bushnell - Key offerings
Exhibits163: Windlas Biotech Pvt. Ltd. - Overview
Exhibits164: Windlas Biotech Pvt. Ltd. - Product / Service
Exhibits165: Windlas Biotech Pvt. Ltd. - Key offerings
Exhibits166: Worth Medicines Pvt. Ltd. - Overview
Exhibits167: Worth Medicines Pvt. Ltd. - Product / Service
Exhibits168: Worth Medicines Pvt. Ltd. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations